|
Feb 2
|
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates
|
|
Feb 2
|
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer
|
|
Feb 1
|
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
|
|
Feb 1
|
What's Going On With Pfizer Stock Today?
|
|
Feb 1
|
U.S. Medicare Drug-Price Negotiations Start Now
|
|
Feb 1
|
Pfizer Inc. (NYSE:PFE) Q4 2023 Earnings Call Transcript
|
|
Feb 1
|
Is the Worst Over for Pfizer?
|
|
Jan 31
|
Seagen acquisition will give Pfizer 'anchor asset' Wall Street desires: Pfizer CEO Bourla
|
|
Jan 31
|
15 Best Low Cost Stocks To Buy Under $75
|
|
Jan 31
|
Pfizer Full Year 2023 Earnings: Misses Expectations
|
|
Jan 31
|
GSK’s RSV Vaccine Is a Blockbuster After Just 4 Months. The Stock Is Up.
|
|
Jan 31
|
GSK sales of RSV vaccine stay strong, beating forecast
|
|
Jan 31
|
Q4 2023 Pfizer Inc Earnings Call
|
|
Jan 30
|
Pfizer (PFE) Q4 2023 Earnings Call Transcript
|
|
Jan 30
|
Pfizer Reports Surprise Profit Despite Continued Covid Sales Downfall
|
|
Jan 30
|
Pfizer CEO doubles down on 2024 guidance, talks Seagen buy
|
|
Jan 30
|
Pfizer Looks to Cancer Therapy, New Drugs to Help Fuel Growth
|
|
Jan 17
|
ETF Closures Hit 3-Year High in 2023
|
|
Jan 16
|
Pfizer (PFE) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
|
Jan 16
|
Pfizer’s Bourla Bets His Pension on Company Stock as CEO Defends Drug Firm
|